Hosted on MSN9mon
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head StudyAlso Read: Is Your Botox Real Or Fake? Counterfeit Boxes Circulate For Widely Used ... Dupixent is the flagship drug of Sanofi SA (NASDAQ:SNY) and Regeneron Pharmaceutical Inc (NASDAQ:REGN).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback